“Major depressive disorder impacts over 280 million people globally. Unfortunately, current antidepressants are not effective for approximately 50% of patients, and many also experience significant side effects, including suicidal thoughts.”
We first anchor the video in a real-world challenge, clearly and with urgency.
“ABVC Biopharma has extracted the active ingredients from the root of the traditional medicine Polygala Tenuifolia plant and encapsulated them to create ABV-1504, a botanical drug that offers enhanced efficacy and safety compared to existing treatments.”
We introduce a new therapeutic approach to improve outcomes with better safety and efficacy.
We explain the mechanism in simple terms, using metaphors to make the science easier to understand.
“ABV-1504 has successfully completed Phase 2 clinical trials, showing improved treatment outcomes over traditional antidepressants, with no reports of suicidal thoughts, severe side effects, or addictive behaviors.”
We end with clinical validation — giving investors confidence in the product’s safety and potential.
.
We use cookies to improve your experience on our site. By using our site, you consent to cookies.
Manage your cookie preferences below:
Essential cookies enable basic functions and are necessary for the proper function of the website.
You can find more information in our Cookie Policy and Privacy Policy.